ATTORNEY NEWSLETTER As chief financial officer for a large hospital operator, Ralph Williams was tasked with monitoring contracts and bill pay between his employer, Healthy Management Associates (HMA) and its partners. After discovering inconsistences in the contracts and payments, Williams began an investigation of the contracts. Williams discovered HMA; a […]

ATTORNEY NEWSLETTER         One lawsuit against Novartis alleges that the pharmaceutical company paid kickbacks to doctors to induce them to prescribe Novartis products over those from other companies.  Those Novartis products were then reimbursed by federal health care programs.  As a result, the federal government is alleged to have paid […]

ATTORNEY NEWSLETTER In Chicago, a whistleblower helped to uncover that Northwestern Memorial Hospital has have violated the False Claims Act. According to whistleblower Audra Soulias, a former employee at Northwestern University, the hospital and university allegedly double-billed Medicare and the National Institutes of Health (NIH) for patient reimbursement. Whistleblower Soulias […]

ATTORNEY NEWSLETTER A CVS subsidiary group – RxAmerica – will pay a $5.25 million settlement in response to false claims allegations against Medicare. Two related complaints were brought on behalf of the U.S. government by whistleblowers under the False Claims Act. These allegations of Medicare fraud involve the Medicare Part […]

McKesson Settlement for $190 Million Under False Claims Act McKesson corporation, a San Francisco-based company and one of the largest pharmaceuticals companies in the world, will pay $190  million as settlement in a whistleblower case under the False Claims Act. Whistleblower David Morgan is a Pennsylvania pharmacist and healthcare auditor […]

Dava Pharmaceuticals Whistleblower Case Settles for $11 Million PRWeb Dava Pharmaceuticals, Inc., has agreed to an $11 million settlement in response to allegations of healthcare fraud. The allegations relate to a false misclassification of certain drugs: Cefdinir, Clarithromycin, and Methotrexate. The alleged misclassification of these drugs as “non-innovator” drugs as […]

 Actavis settles Medicaid fraud case for $84 million Reuters [Article submitted by Dr. Caroline Poplin] Actavis Group, a privately held generic pharmaceutical company based in Iceland, has settled a Medicaid fraud case for $84 million with the state of Texas. According to Texas Attorney General Greg Abbott, Actavis had been […]